This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q26.8 (Other congenital malformations of great veins) | Special Copayment Reduction: V192 (Special copayment reduction for heart disease: 5% copayment for up to 30 days from the registration date) |
| B. Synonyms | Persistent left superior vena cava (PLSVC), great vein malformation NEC, double superior vena cava, absence of the inferior vena cava, other great vein malformations |
| C. Adult onset | Persistent left superior vena cava (PLSVC) is most commonly discovered incidentally in adults during pacemaker or CVC insertion, and is mostly asymptomatic. When it drains into the left atrium and a right-to-left shunt develops, there is a risk of paradoxical embolism. |
| 1. History | First described by Lauth in 1707; the clinical importance of PLSVC was recognized anew after the advent of the pacemaker era |
| 2. Causes | Failure of regression of the left anterior cardinal vein; includes various developmental anomalies of the great veins |
| 3. Genetics | Mostly sporadic; when accompanied by congenital heart disease, possible association with 22q11.2 deletion and NKX2.5 variants |
| 4. General epidemiology | 0.3-0.5% of the general population; PLSVC present in 4.5% of patients with congenital heart disease |
| 5. Pathophysiology | Left superior vena cava → dilated coronary sinus → drainage into the right atrium is typical; direct drainage into the left atrium in 10-20% |
| 6. Symptoms | Mostly asymptomatic with coronary sinus drainage; risk of cyanosis and paradoxical embolism with left atrial drainage |
| 7. Signs | Asymptomatic or mild cyanosis; abnormal left mediastinal shadow on chest radiograph |
| 8. Screening | Discovered incidentally during CVC or pacemaker insertion; suspected when coronary sinus dilation is seen on echocardiography |
| 9. Diagnosis | Confirmed by cardiac CT/MRI; PLSVC verified by left subclavian venography; echocardiography as an adjunct |
| 10. Treatment | Isolated PLSVC of the coronary sinus type requires no treatment; surgical correction for the left atrial drainage type and associated anomalies |
| 11. Prognosis | Isolated PLSVC has a good prognosis; cardiopulmonary bypass plans need modification during cardiac surgery; associated anomalies determine prognosis |
| 12. Prevention | Confirmation when abnormal findings are seen on prenatal echocardiography; PLSVC must be confirmed before surgery; prevention of procedural complications |
| 13. References | Persistent left superior vena cava – considerations in fetal, pediatric and adult populations … and 9 other papers |
The most important and common condition in the category of other congenital malformations of great veins (Q26.8) is Persistent Left Superior Vena Cava (PLSVC). The first anatomical description of this malformation was made by Lauth in 1707, and it was subsequently reported intermittently through autopsy cases over hundreds of years.
As cardiovascular anatomy was systematized in the late 19th and early 20th centuries, research began on the embryological mechanisms of various great vein malformations, including PLSVC. In the 1920s-30s, various malformations included in the Q26.8 category, such as double superior vena cava, agenesis of the inferior vena cava, and persistent azygos vein, were described.
Its clinical importance was re-examined when cardiac pacemaker and central venous catheter (CVC) insertion became widespread in the 1960s-70s. As cases were reported in which, during CVC insertion via the left subclavian vein, the catheter followed an abnormal course because of PLSVC, this malformation came to be recognized by clinicians as an important anatomical variant. Cases in which serious complications occurred during procedures performed without knowing of the presence of PLSVC were recorded in the literature at that time.
In the 1980s-90s, it was recognized that the handling of PLSVC when establishing cardiopulmonary bypass in cardiac surgery significantly affects surgical outcomes. In particular, when PLSVC exists alone without a right superior vena cava (about 10-20% of all cases), venous return to the right atrium occurs entirely via the PLSVC, so the method of establishing cardiopulmonary bypass must be modified.
Since the 2000s, advances in cardiac CT, MRI, and 3D echocardiography have made diagnosis of PLSVC and other great vein malformations more precise. As coronary sinus dilation on fetal echocardiography came to be recognized as an indirect sign of PLSVC, prenatal diagnosis also increased. Currently, early detection of malformations in the Q26.8 category and their confirmation before invasive procedures are becoming established as standard care.
PLSVC results from persistence of the left anterior cardinal vein, which should normally regress during fetal life. In normal development, the left anterior cardinal vein regresses at about 8-10 weeks of embryonic life, and this structure is replaced by a connection to the right superior vena cava via the left brachiocephalic vein. When this regression fails, the vein originating from the left subclavian vein descends along the outer surface of the left atrium and drains into the coronary sinus.
In addition to PLSVC, Q26.8 includes various malformations: ① double superior vena cava (double SVC), ② isolated PLSVC without a right superior vena cava, ③ absence of the inferior vena cava (interrupted IVC with azygos continuation), ④ connection of the inferior vena cava to the left atrium, ⑤ agenesis/defect of the coronary sinus, etc. These malformations occur independently or together with complex congenital heart malformations (heterotaxy syndrome, isomerism syndrome).
Environmental factors (rubella, maternal diabetes, teratogenic drugs) and genetic predisposition may be involved in their development, but most isolated PLSVCs are sporadic malformations without a clear cause.
Isolated PLSVC and other great vein malformations mostly occur sporadically, and no clear single-gene cause has been identified. However, when they occur together with other congenital heart malformations, 22q11.2 microdeletion and NKX2.5, GATA4, and TBX1 gene variants may be associated.
In heterotaxy syndrome, variants in ZIC3 (X-linked), CFC1, ACVR2B, and NODAL pathway genes have been described, and this syndrome is accompanied by various abnormalities of visceral position such as PLSVC, inferior vena cava anomalies, and ectopic liver and spleen. Recurrence of PLSVC within families is rare, but the risk may be higher when there is a family history of congenital heart disease.
Animal model studies have suggested that TBX5 deficiency and abnormal Sema3d signaling are associated with abnormalities in superior vena cava development. However, it is still unclear whether these findings apply directly to humans.
PLSVC is the most common congenital malformation of the thoracic venous system. Its prevalence in the general population is estimated at 0.3-0.5%, and it is markedly higher, about 4.5%, in patients with congenital heart disease. The double superior vena cava form is the most common (80-90% of all cases), and isolated PLSVC accounts for 10-20%.
Among the other malformations included in Q26.8, interrupted IVC (interrupted IVC with azygos continuation) is highly associated with heterotaxy syndrome and is observed in about 70% of isomerism syndromes (asplenia/polysplenia). Because great vein malformations often cause no major clinical problems even when they occur in isolation, the actual prevalence is presumed to be higher than reported.
The detection rate of PLSVC is higher in patients undergoing pacemaker insertion or central venous catheter insertion than in the general population, because these patients often have underlying heart disease.
PLSVC typically drains into the right atrium via the coronary sinus. The coronary sinus becomes markedly enlarged as it receives continuous flow from the PLSVC, and this is an important indirect sign of PLSVC on echocardiography. The coronary sinus drainage type has almost no hemodynamic significance and is mostly asymptomatic.
However, in about 10-20%, the PLSVC drains directly into the posterior wall of the left atrium without a coronary sinus. In this case, systemic venous blood (deoxygenated blood) flows directly into the left atrium, forming a right-to-left shunt, with reduced arterial oxygen saturation and a risk of paradoxical embolism. In isolated PLSVC, if there is no left brachiocephalic vein, all venous return from the head, neck, and left upper limb occurs via the PLSVC.
In interrupted IVC (interrupted IVC with azygos continuation), venous return from the lower limbs and abdomen returns to the superior vena cava via the azygos or hemiazygos vein, and the hepatic veins connect independently to the heart. This malformation requires a change in the method of establishing cardiopulmonary bypass during surgery.
The coronary sinus type of PLSVC, which accounts for most of Q26.8, is asymptomatic and discovered incidentally. Symptoms are determined by the severity of associated cardiac malformations. In the left atrial drainage type of PLSVC, mild cyanosis, especially reduced oxygen saturation during exercise, may occur, and stroke due to paradoxical embolism can occur.
Interrupted IVC is mostly asymptomatic, or the symptoms of other associated malformations predominate. Some associations with atrial fibrillation and arrhythmias have been reported, but a causal relationship is unclear. PLSVC is also sometimes discovered when, during pacemaker or defibrillator insertion, lead insertion via the left subclavian vein is impossible or follows an abnormal course.
In most cases there are no specific findings on physical examination. In the left atrial drainage type, mild central cyanosis and clubbing of the fingers may appear. On chest radiography, abnormal widening of the left mediastinal shadow (a shadow following the mediastinal course of the PLSVC) may be observed. On echocardiography, marked enlargement of the coronary sinus (diameter >5mm) is an important sign suggesting PLSVC.
PLSVC should be suspected when a chest radiograph taken after CVC insertion shows the catheter following an abnormal course descending along the left side. Right bundle branch block, QRS abnormalities, and atrial fibrillation may be present on the electrocardiogram, but they are not specific. PLSVC is also considered when the central venous pressure measured from the left upper limb is abnormally high or catheter resistance is strong.
When coronary sinus dilation is found on prenatal fetal echocardiography, PLSVC is suspected and further tests are performed. On fetal echocardiography, if the coronary sinus diameter is 25% or more of the left atrial diameter, PLSVC is likely. Fetal MRI helps to directly visualize the course of the PLSVC.
In adults, PLSVC can be diagnosed by coronary sinus dilation on transthoracic echocardiography, particularly when, on contrast echocardiography after injection of saline into the left jugular vein, contrast appears first in the coronary sinus (before the right atrium). Chest CT and incidentally discovered abnormalities of the CVC insertion route also serve a screening role.
Cardiac CT angiography (CTA) is the standard test for identifying the course, connections, and associated malformations of the PLSVC in three dimensions. It is particularly essential for determining the exact anatomy of the PLSVC before cardiac surgery. Cardiac MRI (CMR) provides hemodynamic assessment and visualization of the PLSVC course simultaneously without radiation.
Left subclavian venography is a direct method for diagnosing PLSVC, in which contrast is injected into a vein of the left upper limb to confirm the route by which the PLSVC connects to the coronary sinus or left atrium. Transesophageal echocardiography (TEE) is useful for directly visualizing the size of the coronary sinus and the orifice of the PLSVC. Cardiac catheterization is performed when assessment of associated cardiac malformations or measurement of pulmonary vascular resistance is needed.
Isolated PLSVC draining into the coronary sinus requires no specific treatment. However, surgical correction is needed when there are associated cardiac malformations or in the direct left atrial drainage type. At surgery, the PLSVC is ligated or transposed to the right atrium; in double superior vena cava, if a left brachiocephalic vein is present, the PLSVC can be safely ligated.
In patients undergoing cardiac surgery (cardiopulmonary bypass), when the presence of PLSVC is confirmed, it must be reflected in the surgical plan. Cannulation for cardiopulmonary bypass via the PLSVC or additional cannulation for right atrial decompression is needed. During pacemaker insertion, a special approach inserting the leads via the PLSVC is required.
For interrupted IVC, a surgical plan is established according to the associated malformations, and during single-ventricle repair such as the Fontan operation, special handling of systemic venous drainage via the azygos vein is necessary. All of these procedures should be performed by a specialized congenital cardiac surgical team.
The prognosis of isolated PLSVC of the coronary sinus type is very good, and with appropriate precautions (confirmation before invasive procedures), a normal life without complications is possible. Surgical correction is recommended for the left atrial drainage type because of the risk of paradoxical embolism and cyanosis, and the prognosis after correction is determined by the type of associated malformations.
If PLSVC is not identified in advance, cardiopulmonary bypass-related complications (oxygen deficiency, myocardial injury) may occur during cardiac surgery, so it must be confirmed on preoperative imaging. Overall, the long-term prognosis of isolated Q26.8 malformations without associated anomalies does not differ from that of the general population.
There is no specific method of preventing Q26.8 malformations, but early identification of PLSVC when coronary sinus dilation is found on prenatal echocardiography helps postnatal clinical management. Procedure-related complications are prevented by operating a protocol that always checks for great vein malformations before invasive procedures (CVC, pacemaker, cardiac catheterization).
When planning cardiac surgery, the presence of great vein malformations must be checked on preoperative imaging (CT or MRI) so that the cardiopulmonary bypass plan can be established appropriately. When there is a family history, early identification of associated cardiac malformations through genetic counseling and detailed prenatal ultrasound is recommended.
Irwin RB, Greaves M, Schmitt M. Persistent left superior vena cava – considerations in fetal, pediatric and adult populations. Echo Res Pract. 2017;4(2):R33-R40. DOI: 10.1530/ERP-16-0038. PMID: 28191144.
Biffi M, Boriani G, Frabetti L, et al. Left superior vena cava persistence in patients undergoing pacemaker or cardioverter-defibrillator implantation. Chest. 2001;120(1):139-144. DOI: 10.1378/chest.120.1.139. PMID: 11451831.
Nsah EN, Moore GW, Hutchins GM. Pathogenesis of persistent left superior vena cava with a coronary sinus connection. Pediatr Pathol. 1991;11(2):261-269. DOI: 10.3109/15513819109064766. PMID: 2067289.
Sarodia BD, Stoller JK. Persistent left superior vena cava: case report and literature review. Respir Care. 2000;45(4):411-416. PMID: 10772367.
Povoski SP, Khabiri H. Persistent left superior vena cava: review of the literature, clinical implications, and relevance of alterations in thoracic central venous anatomy as pertaining to the general principles of central venous access device placement and venography in cancer patients. World J Surg Oncol. 2011;9:173. DOI: 10.1186/1477-7819-9-173. PMID: 22152050.
Goyal SK, Punnam SR, Verma G, Ruberg FL. Persistent left superior vena cava: a case report and review of literature. Cardiovasc Ultrasound. 2008;6:50. DOI: 10.1186/1476-7120-6-50. PMID: 18957110.
Rieder M, Habertheuer A, Kocher A, et al. Persistent left superior vena cava in cardiac congenital surgery. Pediatr Cardiol. 2014;35(1):1-6. DOI: 10.1007/s00246-013-0743-z. PMID: 23821295.
Ratliff HL, Yousufuddin M, Lieving WR, et al. Persistent left superior vena cava: case reports and clinical implications. Int J Cardiol. 2006;113(2):242-246. DOI: 10.1016/j.ijcard.2005.10.031. PMID: 16337037.
Schreiber C, Cleuziou J, Cornejo JL, et al. Left-sided superior vena cava without brachiocephalic vein: technical considerations for cardiac operations. Interact Cardiovasc Thorac Surg. 2008;7(4):620-623. DOI: 10.1510/icvts.2008.178491. PMID: 18490375.
Bartram U, Wirbelauer J, Speer CP. Heterotaxy syndrome – asplenia and polysplenia as indicators of visceral malposition and complex congenital heart disease. Biol Neonate. 2005;88(4):278-290. DOI: 10.1159/000087625. PMID: 16254454.